Looks like they are not going to announce the IDE submission after all. So we should hear the FDA decision within the next 30 days according to FDA’s processing guidelines. That could be the huge turning point for the company.
Not Advice, DYOR
Ann: Clinical Milestone - 100 patients treated with DurAVR THV, page-29
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.55 |
Change
-0.010(0.18%) |
Mkt cap ! $85.91M | |||
| Open | High | Low | Value | Volume |
| $5.31 | $5.60 | $5.31 | $52.23K | 9.674K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 188 | $5.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.69 | 122 | 1 |
View Market Depth
| Last trade - 15.11pm 08/08/2025 (20 minute delay) ? |
| AVR (ASX) Chart |